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Age-related macular degeneration (AMD) is one of several retinal 
degenerative diseases that results in a person’s loss of vision due to retinal damage 
(1). The retina contains two types of photoreceptors called rods and cones. Rod 
photoreceptors are light sensitive and abundant in the retina. In contrast, cone 
photoreceptors are active only at higher levels of light and are scarce in the retinal 
layer (2). AMD impairs cone photoreceptors with no means to regenerate and this 
may eventually lead to the damage of other retinal cells (1). Preceding research 
has shown that human embryonic stem (hES) cells and induced pluripotent stem 
(iPS) cells in vitro can be differentiated into retinal progenitors, allowing these 
cells to eventually mature into specific cell types. The overall goal of this research 
is to bias cone photoreceptor fate in these hES differentiated retinal stem cells in 
vitro using transient overexpression of messenger RNA. Regenerating cone 
photoreceptor cells in vitro could facilitate cell replacement therapy and improve 
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Age Related Macular Degeneration: 
Many forms of eye diseasess causing visual impairment exist in the United 
States. Amongst the retinal degenerative diseases, the National Eye Institute 
recognizes age related macular degeneration (AMD) as the leading cause of 
blindness for people 50 years or older. The two main types of AMD are dry and 
wet. Dry AMD is distinguished by an accumulation of yellow protein deposits 
known as drusen, while, wet AMD is recognized by new blood vessel growth, a 
part of the body’s natural healing response. These abnormal vessels usually grow 
in an unstable fashion and are leaky, allowing blood to enter into the eye, causing 
further visual impairment (1).  
Regardless of the type of AMD, this form of retinal degenerative disease is 
aggressive and ultimately causes damage to the central vision as shown in figure 
1. About 14% of people who have dry AMD develop the wet form over time, 
which is more progressive (1). Currently, there are treatment options for the wet 
form, including taking high doses of vitamins or minerals, injections of anti-
vascular endothelial growth factor into the eye, or some form of laser surgery. 
However, these treatments only help ablate the abnormal blood vessel formation, 
and often leave some scaring which further impedes central vision. To date, there 
is no cure for AMD. Furthermore, the cells that are harmed or destroyed by the 
AMD disease do not have the capacity to regenerate on their own. Thus once a 
cell is damaged, it is lost forever. The ability to regenerate lost cells using stem 
cell therapy is seen as a potential viable solution (2). In this study, we proposed a 
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method for developing cells in vitro that could replace cells damaged by retinal 















The retina, a pseudostratified epithelial membrane that lines the back of the 
eye, is vulnerable to a variety of retinal degenerative diseases such as AMD. This 
membrane is viable to vision because it is light sensitive, which allows for image 
processes to occur (3). The cells responsible for vision are known as 
photoreceptors and respond to light photons. Light travels through the thick layers 
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of the retina before triggering the photoreceptors (figure 2). The absorption of 
photons by the photoreceptors is first translated into a biochemical message and 
then an electrical message which stimulates all the downstream neurons of the 
retina. When this biochemical message reaches the ganglion cells, its long axons, 
that make the up the optic nerve, help transport the information to the brain, which 
is then perceived into an image (4).  
As stated earlier, photoreceptors are the cells involved in visual response. 
The two types of photoreceptors are the rods and cones. Both photoreceptors are 
located throughout the retina including the macula, an area in the center of the 
retina. Rod photoreceptors are extremely light sensitive, and only detect the 
presence or absence of light; rods are responsible for black and white vision and 
are vastly abundant, with approximately 120 million rods found around the 
periphery of the macula (5). On the other hand, cones reside in the fovea, the 
central area of the macula (figure 2B). Cones make up the majority of central 
vision and respond to high levels of light. Often referred to as the color 
photoreceptors, the cones are far less abundant then rods, with an estimate of 
about 6 to 7 million in the retina and enriched around the macula and fovea (6). 
Since AMD causes damage to the area known as the macula, and more 


























Figure 2:  
(A) The picture to the left shows the light sensitive layer at the back of the eye known as the retina. 
The picture to the right demonstrates how light travels through this pseudostratified layer and 
reaches the photoreceptors, which send a signal back to the brain through the optic nerve. (B) The 
picture to the left shows the optic nerve and close by an area in the center of the retina known as 
the macula. The picture to the right demonstrates a head on view of the macula and the 





Stem Cell Research: 
Vision restoration through stem cell transplantation has been a vastly 
studied area of interest. This could be an applicable therapeutic approach for many 
retinal degenerative diseases such as AMD. In order for treatment to be 
successful, the regeneration of retinal cells needs to be accomplished first. The 
growth and development of retinal neural cells, including rod photoreceptors in 
vitro using stem cells have been developed by several research groups including 
the Lamba lab (7). However, the specific growth of cone photoreceptor cells in 
vitro has not yet been successful for several reasons, especially because the exact 
genes and specific pathways that regulate cone identity are unknown. Successful 
development of these cells are essential for many reasons. First, photoreceptor 
cells are in close proximity to each other and studies have shown that damage to 
one neuronal cell is able to affect an adjacent neuronal cell (8). These types of 
damages could lead to other diseases such as retinitis pigmentosa that affect rod 
photoreceptors. Generating and transplanting cone photoreceptors could impact 
rod photoreceptor health. Moreover, cone photoreceptor generation could further 
retinal degenerative disease studies and develop new approaches such as cell 
replacement therapy for retinal degenerative diseases, like AMD. 
Cell replacement therapy can be achieved through use of stem cells and 
offers a viable approach to treating retinal degenerative diseases. Stem cells have 
three significant properties: 1) the cells have limitless replication capacities, 2) the 
cells are unspecialized and 3) the cells can differentiate into specialized cell types 
(9). There are no known retinal stem cells, but with innovations in human 
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embryonic stem (hES) cells, hES cells can be differentiated into retinal stem cells. 
These hES cells are derived from embryos that have been artificially inseminated 
in vitro. These cells have been shown to have the ability to self-replicate and are 
pluripotent. Pluripotency allows for an undifferentiated cell to be differentiated 
into any cell type. Additionally, the generation of induced pluripotent stem (iPS) 
cells by Shinya Yamanaka is a beneficial new way to regenerate specific cell 
types from different cell lineages. Induced pluripotent stem cells are derived from 
adult somatic cells and can then be regenerated into undifferentiated pluripotent 
stem cells using four genes, Oct4, Sox2, cMyc, and Klf4 (10). Advances such as 
iPS cells have become useful when overcoming obstacles in both research and 
ethical concerns.  
Equally human embryonic and induced pluripotent stem cells have the 
capabilities of differentiating into specialized cells (9, 11). Previous studies in our 
lab have demonstrated that both hES and iPS cells can differentiate into retinal 
cells and mature into transplantable rod photoreceptors successfully (12). 
Mammalian retinal differentiation can be achieved in many ways by altering 
several signaling pathways. Forebrain and retinal development involves the co-
inhibiting bone morphogenetic protein (BMP) and Wnt signaling pathways (13). 
In support of this Barrantes and others demonstrated that mice expressing mutated 
dickkopf1 (dkk1) and noggin, two known BMP and Wnt antagonists, developed 
major head and eye defects.   
Furthermore, the Notch-Delta pathway has been shown to be essential for 
inducing retinal progenitor cells (14), whereas insulin like growth factor-1 (IGF-1) 
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has been shown to be necessary for eye development (15). Osakada and others 
established a protocol demonstrating the use of specific small molecules to induce 
retinal differentiation as an efficient and cost effective way to produce 
photoreceptors, which has been replicated in our lab (16). The small molecules 
used were SB4131542, IWR-1, and LDN193189 along with IGF1 (a recombinant 
protein). These small molecules and protein are collectively known as ISLI. 
Neural retinal differentiation induction can be traced through many markers. For 
example, LIM homeobox (LHX2) and retinal homeobox protein (RX) are eye field 
transcription factors that play essential roles in mammalian eye development. 
Moreover, photoreceptor differentiation can be seen through the upregulation of 
several transcription factors including cone-rod homeobox (crx), neurod1 (ND1), 
and Recoverin (REC) (17). More specifically thyroid hormone receptor beta 2 
(Thrb2) and retinoid receptor X gamma (RXRG) are cone photoreceptor specific 
markers (18). 
 
Cone Photoreceptor Development: 
  During neural retinal differentiation via hES or iPS cells in vitro, many 
specific genes are upregulated at various time points, which likely explains the 
genesis of some retinal cells (17, 18). Cone photoreceptors are one of the first 
cells developed during retinal neurogenesis (19). However, the exact genes that 
bias cone photoreceptor development still remain unclear. Understanding which 
photoreceptor genes are expressed early on could offer insights into the origin of 
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cone cells and could elucidate the development of cone photoreceptor cells from 
hES or iPS cells in vitro. 
Unpublished data from our collaborator, Dr. Joseph Brzezinski (Colorado 
University, Colorado, CA), identified three early possible cone photoreceptor 
transcription factors through RNA sequencing. This initial data was obtained 
using differentiated mouse retinal stem cells where notch signaling was inhibited 
at day 14.5, and thus driving retinal neural induction. Birthing studies 
demonstrated that this specific time point was seen to give rise to a peak in cone 
photoreceptor development (20). OTX2, a known photoreceptor gene, 
ONECUT1, and BLIMP were all upregulated synchronously at 14.5 days during 
10,12, and 18 hours following notch inhibition. Trb2, a mature cone photoreceptor 
marker, was upregulated later at 48 hours. This preliminary analysis suggested 
that OTX2, ONECUT1, and BLIMP could potentially be responsible for biasing 
cone photoreceptor cell fate. Further studies were necessary in order to develop a 
solid understanding of whether and how these genes may contribute to retinal cell 
progenitor fate and cone photoreceptor development.  
The goal of this study is to investigate whether cone photoreceptor cells can 
be developed in vitro by overexpressing OTX2, ONECUT1, and BLIMP using 
differentiated retinal neural stem cells. This overexpression was done through 
messenger ribonucleic acid (mRNA) transient transfection of the three genes. 
Using mRNA has many advantages, in that 1) mRNA will not harm the host 
genome, 2) mRNA does not need to be localized in the nucleus and 3) it allows 
for faster interpretation of experimental results (21). Although mRNA has its 
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benefits, RNA is known to rapidly degrade, hence DNA transfections have been 
traditionally used more often. However, a recent study bypassed this problem 
where researchers confirmed their product (a stable RNA vector) could be 
transfected in human cells for a longer duration of about 36 hours (22). Using 
mRNA for this research allowed us to study cone cell origin. Developing cone 
photoreceptor cells in vitro could potentially transform the way retinal 
degenerative diseases are studied and may potentially be used as a means for cell 
replacement therapy for diseases such as age related macular degeneration.  
 
Materials and Methods 
Plasmid Transformation 
DNA plasmids (OTX2, ONECUT1, and BLIMP) were provided by Dr. 
Joseph Brzezinski (University of Colorado, Boulder, CO). Plasmids were used to 
transform competent One Shot E. coli bacteria (Thermo Fisher, Cincinnati, OH), 
using manufacture’s protocol. Bacteria were plated on Luria Broth (LB) media 
(Thermo Fisher, Cincinnati, OH) supplemented with either ampicillin or 
kanamycin, depending on resistance. Plates were incubated overnight at 37˚C. 
From each transformation, three bacterial colonies were picked the following day 
and grown for 1 hour at 37˚C in 15-ml of LB media containing the matching 
antibiotic.  This bacterial culture was then used to inoculate 250 ml of LB media 
containing the corresponding antibiotic (1:1000 µg/µl). The flask was incubated 





Plasmid DNA was purified using the Maxi kit (IBI Scientific, Peosta, IA) 
according to the manufacturer’s protocol. The DNA pellet was re-suspended in 
300 µL of elution buffer. The DNA was quantified via Thermo Scientific 
NanoDrop 2000 Spectrophotometer. 
DNA Enzyme Digest and Extraction 
DNA enzyme digestion reactions were setup as follows: 24 µg of purified 
plasmid DNA, 6 µl of Nhe1, 10 µl of BSA, 1 µl of 2.1 Buffer, and 
diethylpyrocarbonate (DEPC) water to bring the total volume to 100 µl. Nhe1, 
bovine serum albumin (BSA), 2.1 Buffer were purchased through New England 
BioLabs (Ipswich, MA). The samples were placed in a 100-µl PCR tube and 
incubated for 4 hours at 37˚C, followed by 15 minutes at 65˚C in a T100 Thermo 
cycler (Biorad, Hercules, CA) to inactivate the NheI restriction enzyme. Enzyme 
digestions were confirmed with a 1.5% LE quick dissolve agarose electrophoresis 
gel (GeneMate, Kaysville, UT), running at 100V for 30 minutes. 100 µl of the 
digested DNA was mixed with 100 µl of 1:1 phenol-chloroform in a 1.7-ml 
eppendorf tube for DNA extraction. The mixture was centrifuged for 5 minutes at 
11,000 RPM. The upper layer was transferred to a new eppendorf tube and 
washed with 1 mL of 100% ethanol.  This was centrifuged at 11,000 RPM for 10 
minutes to obtain a DNA pellet, which was re-suspended in 30 µl of (DEPC) 





Messenger RNA Synthesis 
Nhe1 cut DNA plasmids (control CHERRY, BLIMP, ONECUT1, and 
OTX2) were run through the HiScribe T7 ARCA mRNA kit according to the 
manufacturer’s protocols for mRNA synthesis. Synthesized mRNA was re-
suspended in 50 µl of RNase-free water and quantified through nano 
spectrometry. A 1.5% agarose electrophoresis gel (GeneMate) was done in order 
to confirm the quality of RNA bands.   
 
Retinal differentiation of human embryonic stem cells 
Human embryonic stem cell lines (hESC) H1 and WA01) were purchased 
from WiCell Research Institute (Madison, WI). Cells were maintained in 6 well 
plates in essential 8 media (ES8), which consisted of 250 ml of Essential 8 basal 
media (Thermo Fisher, Cincinnati, OH), 1% penicillin-streptomycin amphotericin 
B (Lonza, City and State), and 1% Essential 8 Supplement (Gibco). The hES cell 
differentiation media contained 10% knockout serum replacement (KSR), 0.1% 
recombinant Insulin Growth Factor 1 (R&D Systems, Minneapolis, MN), and 
small molecules in the following concentrations: 0.1% SB413542 (Stemgent, City 
and State), 0.1% IWR-1 (Sigma Aldrich, St. Louis, MO), and 0.01% LDN193189 
(Stemgent). Cells were kept on differentiating media for 5 days and then 
dissociated using 1 ml of Tryple (Corning, Manassas, VA). Half media changes 
with neural stem cell (NSC) media plus differentiating media would be done up 
until day 7, followed by full media changes with only NSC media. Differentiated 
neural retinal cells were sustained indefinitely in NSC media consisting of 
12 
 
DMEM/F-12 1:1 (Hyclone, Logan, Utah), 1% penicillin-streptomycin 
amphotericin B (Lonza), 0.5% Fetal Bovine Serum (FBS; Atlanta Biologicals), 
1% sodium bicarbonate (Corning), 1% HEPES Buffer (Corning), 1% MEM 
nonessential amino acids (Corning), and 1% N1 Supplement (Sigma Aldrich). 
 
Human Embryonic Kidney (HEK) Cells 
Passage 1 HEK cells were kept in media composed of 70% DMEM/High 
Glucose (Hyclone), 10% penicillin streptomycin amphotericin B (Lonza), and 
20% fetal bovine serum (Atlanta Biologicals, Miami, FL). Cells were grown to 
70% confluence for transfection experiments. 
 
Transfection Protocol 
Transfections were carried out on hES neural retinal stem cells between one 
and three months following differentiation (during earlier retinal development). 
Cells were dissociated with 1 ml of accutase (Sigma Alderich) per well (usually 2 
wells from a 6-well plate needed) and transferred onto a 24-well plate coated with 
matrigel. When approximately 70% cell confluence was reached (about 2-3 days), 
transfections were performed. Using Stemgent’s RNA Transfection Kit 
(Cambridge, MA), cells were transfected with the mRNA (CHERRY, BLIMP, 
ONECUT1, AND OTX2) synthesized via HiScribe T7 ARCA mRNA kit.  For 
each reaction, 0.5 µg of mRNA, 1 µl of Stemfect reagent, and 25 µl of Stemfect 
buffer were mixed and incubated at room temperature for 15 minutes. This 
mixture was then applied to one well of the 24-well plate, along with 2 ml of NSC 
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media. The reactions were left overnight at 37oC and successful transfections were 
confirmed with the CHERRY control mRNA. If taken in by the cell, the 
CHERRY mRNA fluoresces red under the fluorescent microscope. Transfection 
experiments were left 7 days post transfection with daily changes of NSC media 
in order to see if mRNA production is validated after one week. Analysis of all 
transfections in vitro was done through quantitative RT-PCR.  
 
RNA extraction, Reverse Transcription and Quantitative PCR  
RNA extraction from wells was done using Direct-zol RNA MiniPrep kit 
according to manufacturer’s protocol (Zymo Research, Tustin, CA). RNA samples 
were resuspended in 30 µl of DEPC water and the yield was determined using the 
Thermo Scientific NanoDrop 2000 Spectrophotometer. Synthesis of cDNA was 
done with iScript cDNA synthesis kit (BioRad) per manufacturer’s protocol. 250 
ng of total RNA was used, and the rest of the kit’s instructions were followed. The 
reactions were incubated in a T100 Thermal Cycler machine per kit’s instructions. 
Quantitative RT- PCR. Analysis was performed on the CFX Connect Real Time 
PCR Detection System (BioRad). Primers used in this study are listed in Table 1. 
 










GGT GTA ACG CAA 




TTC TCT G 
GAT AAA CCA AGT 








CAT CTC TTT GCC 






CCA CTT TCT GAA 






GGT TGC TTT AGA 







AGA AGT TGC CAT 







CAC GTC GTA GAG 






TTG GTA ACA GGG 






TGG TCT TCA CAT 




CGA CTT C 





Cells were fixed with 2% Paraformaldehyde (Alfa Aesar, Sparks, NV) for 
45 minutes at 4˚C in the dark. Paraformaldehyde was aspirated off, and cells were 
washed two times at five minutes each with 1X phosphate-buffered saline (PBS). 
Following the washes, samples were blocked with a block solution consisting of 
1X PBS and 10% normal donkey serum (EMD; Millipore Darmstadt, Germany) 
for one hour.  Primary antibodies were diluted in blocking solution according to 
Table 2. Primary antibodies were distributed to fixed cells and were incubated 
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overnight at 4°C in the dark. The cells were washed two times as described above. 
Secondary antibodies (Santa Cruz Biotech, Santa Cruz, CA) were added at a 
1:500 dilution in block solution, and then placed on cells for one hour at 4°C in 
the dark (not shown in table). The secondary solution was removed with two 
washing steps as described above. DAPI (Enzo Life Sciences Farmingdale, NY) 
was added to the cells for 30 seconds, and cells were washed an additional two 
times. Samples were then mounted on glass slides (VWR, Radnor, PA) and 
viewed using Fluoromount-G (Electron Microscopy Science, Hartfield PA). 
 
Table 2 – List of Primary Antibodies 
















R&D Systems 1:100 
 
 
Animal Transplantation and Samples 
Human retinal stem cells were generated using the differentiation protocol, 
infected with GFP plasmid and transfected using the transfection protocol. The 
cells were exported and implanted into IL2rg null mice (graciously performed and 
provided by Dr. Jie Zhu, Buck Institute for Research on Aging, Novato, CA).  
Upon receiving mouse retina samples, staining for photoreceptors was carried out 





Development of the Neural retinal stem cell differentiation protocol: 
 
The Lamba lab has established several retinal neural differentiation 
protocols using both hES and iPS cells. The specific protocol chosen here used 
four molecules to drive neural retinal differentiation (Figure 3A). These molecules 
differentiated stem cells in a less costly and more accelerated manner, where 
differentiation is only happening for a few days as opposed to weeks. In this 
particular investigation, the human embryonic stem cell line referred to as H1 
cells was the main cell type used for neural retinal differentiation. However, an 
iPS cell line called Lonza, generously donated by the Zeng lab at the Buck 
Institute (Novato, CA) was also used for the same experiments (data not shown). 
The results below correspond to H1 cells; however, the data for the Lonza cells 
was not significantly different. Neural retinal differentiation occurred best when 
the differentiation cocktail media was added to these undifferentiated cells at 70% 
well confluency and an average cell size of 4µm (figure 3B). This allowed the 
undifferentiated cells to properly differentiate and spread out.  
The differentiation cocktail media included four main molecules, insulin 
growth factor1 (IGF1), SB4131542, IWR-1, and LDN193189. These are 
collectively referred to as ISLI and have been shown to drive neural retinal 
differentiation (16). When cells reached 100% confluency at day 5, they were 
dissociated. In order to get cells acclimated to the regular neural stem cell media 
(NSC), half of the media was changed until day 7. Complete NSC media changes 
continued after day 7. Typically by days 15-30, morphological changes were 
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noticeably visible in the differentiated cells. The first confirmation towards 
successful neural retinal differentiation occured when neural clusters or neural 
rosettes began to develop. These neural areas were manually picked and expanded 
for future experiments (Figure 3B – 3E). In this specific experiment, cells were 
grown and maintained until around 90 days after differentiation media was added 
to them at Day 0.  
 At the three-month time point, quantitative RT-PCR data was used to 
confirm effective neural retinal differentiation, where both eye field and retinal 
transcription factors were shown to be upregulated (Figure 1F). Taken together, 
this data confirmed that H1 cells could be successfully differentiated into neural 
retinal stem cells. These differentiated cells were then expanded until they reached 
the appropriate age (a potential period for cone photoreceptor development) for 
the next phase of the experiment, which was to conduct transient mRNA 





















































(A) A schematic of hES cell retinal differentiation, highlighting the important protocol time points 
from Day 0 – Day 90. (B-D) Images representing neural retinal differentiation are all visible at 
10X. Border color is consistent with time point on the timeline in figure 3A. (B)The hES cells 
were placed in a cocktail of differentiation media for 5 days. (C) At 30 days, hES cells began to 
develop large neural areas. (D) These neural clusters were dissociated and expanded. (E) Neural 
retinal cells at 3 months. (F)Three months differentiated neural retinal stem cells were crossed 
compared with undifferentiatied hES cells using q-RT PCR. H1 differentiated stem cells 
demonstrated a significant in expression of eye field transcription factors, Lhx2 and Rx. Also, there 
was an increase in Crx, cone rod homeobox, and Nrl, a rod photoreceptor marker (24). 
 
Synthesis of mRNA and working parameters for transient transfection: 
Transfection protocols typically involve transfecting DNA, however, for the 
experiments in this project, mRNA was used instead. As mentioned in the 
introduction, there are multiple advantages for selecting mRNA. Here, we used 
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Toshinori’s approach (22) for stabilizing RNA during the duration of the 
transfection. In short, our collaborators (Dr. Joseph Brzezinski, Colorado 
University, Aurora, CO) developed and provided pSLU expression plasmids for 
the following genes— BLIMP, ONECUT1, OTX2, and CHERRY (control) 
(Figure 4A). The genes were inserted into the multiple cloning site (MCS) of the 
pSLU vector. Downstream of this MCS were sequences for the 3′ UTR of the 
Venezuelan equine encephalitis virus (VEEV), which served as a stabilizing motif 
and recognition site for the NheI restriction enzyme that was later used for 
linearization. After DNA linearization, synthesis of mRNA occurred with the 
HiScribe kit and mRNA synthesis was confirmed by gel electrophoresis (data not 
shown).  
In order to save time and resources (while mRNA synthesis was in 
progress) a green fluorescent protein (GFP) and human embryonic kidney (HEK) 
cells were used to test a variety of transfection parameters for experiments to 
follow. We first tried using electroporation as the vehicle for transfection, 
however, a high degree of cell death was observed along with only a few single 
cells being transfected (data not shown).  
After several failed electroporation attempts, different chemical transfection 
reagents were then tested. Stemfect (from Stemgent) was the chemical reagent 
with the best results. We also transition the transfection into a 24 well plate, which 
required less Stemfect reagent and GFP concentration, and this reduced the 
number of cell deaths and increased the number of positive transfectants in HEK 
cell (Figure 4B). Once the transfections parameters were established, GFP 
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transfection was then tested on the H1, the human neural retinal differentiated cell 
line that would be used for the remainder of the study. Results in figure 4C 
showed that the same conditions (Figure 4B) were able to successfully transfect 
the differentiated hES cell line with little to no cell death and the majority of the 
cells had GFP (figure 4C). 
 Next, the HEK cells were transfected with the control mRNA, CHERRY. 
CHERRY is another fluorescent marker like GFP, except it fluoresces red. 
Following transfection of HEK cells with CHERRY mRNA, cells showed an 
abundance of red fluorescence under the microscope, indicating that the 
transfection parameters were working (data not shown). Following the successful 
transfection of the control mRNA, the synthesized mRNAs for each of the gene of 
interest were separately transfected into HEK cells using the same conditions. 
Cells were collected post transfections and analyzed with qRT-PCR. Each gene 
(BLIMP, ONECUT1, and OTX2) demonstrated an overexpression in the 
respectively transfected HEK cells compared to non-transfected HEK cells (figure 
4D). With these results, we moved forward with transfecting the H1 cells, first 
















































Figure 4: (A) A schematic of a pLSU vector, showing the relative location of the T7 and T3 
promoter with the  multiple cloning site (showing  BLIMP as an example), the six repeat sequences 
of VEEV 3’UTR, and the Nhe1 restriction enzyme.  (B) Fluorescent positive HEK cells indicated 
that GFP transfection using the Stemfect reagent was effective. (C) Fluorescent positive cells 
indicated that GFP transfection using the Stemfect reagent was effective on the H1 line. All images 
were taken at 10X. (D) Transfected HEK cells showed an increase level of gene expression versus 
the non-transfected. 
 
Transfection of H1 differentiated neural retinal cells with CHERRY mRNA: 
 Having established the parameters for neural retinal differentiation and 
transient transfection, the next phase of the experiment could proceed, transfecting 
the control CHERRY mRNA into hES (H1) cells. Transfections where done on 
differentiated neural retinal cells 3 months of age, a peak in human cone 
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photoreceptor development. These cells were plated on a 24 well matrigel plate 
and grown until about 70% confluence, and cells were transfected with CHERRY 
mRNA. Both microscopy and PCR analysis were used to confirm transfection and 
expression of the CHERRY (Figure 5). CHERRY expression (red fluorescence) 
was observed the first day after transfection (Figure 5A).  
 The strong expression of CHERRY protein was sustained five days after 
transfection, then the expression slowly decreased after 5 days, until it completely 
disappeared around day 14. Normal media changes were done and no cell death 
was observed during the 14 day period (data not shown). RNA was extracted on 
day 5, day 7, day 10 and day 14. On day 7, qRT-PCR data showed a seven-fold 
increase in CHERRY expression in transfected H1 cells compared to mock 
transfected cells (Figure 5B). RNA was also analyzed for the other days using 
qRT-PCR, and consistent with the fluorescent microscopy, the CHERRY 
expression gradually decreased until 14 days post-transfection (data not shown). 
 This data confirmed that the transient mRNA transfections were successful 
in the human embryonic stem cell-derived retinal neural stem cells (3 months of 
age) and that expression of the gene of interest occurred after no more than 7 days 
post transfection. Therefore, we proceeded with the main objective of our 
experiment, overexpressing the three early retinal genes (BLIMP, ONECUT1, 


































(A) CHERRY control transfection proved effective via fluorescent cells. Picture was taken at 10x, 
measuring 4µm cells. (B) Quantitative RT-PCR done 7 days post transfection demonstrates an 




Transfection of H1 differentiated neural retinal stem cells confirms BLIMP, 
ONECUT1 and OTX2 transient mRNAs: 
 After positive CHERRY transfection was confirmed, H1 cells were 
transfected with mRNA for BLIMP, ONECUT1 (OC1), and OTX2. Following the 
same protocol established earlier, transfections were done first with single genes 
(i.e. BLIMP or OC1 only), then with a combination of two genes (i.e. BLIMP and 
OC1), and finally with all three genes (BLIMP, OC1, OTX2, also referred to as 
BOO). Since BLIMP, OC1, or OTX2 mRNAs do not have a fluorescent tag, 
validation of mRNA overexpression was seen through qRT-PCR 7 days post 
transfection. Results in figure 6A confirmed that transfected H1 cells did indeed 
overexpress BLIMP, OC1, and OTX2. CHERRY mRNA was used as our control, 
and cells transfected with CHERRY mRNA did not express any of the genes of 
interest— BLIMP, OC1, and OTX2.  
 Following transfection, we further analyzed how the transfection of each 
individual mRNA translated to gene expression. As expected, H1 cells transfected 
with BLIMP mRNA overexpressed BLIMP. The same was observed for OC1 and 
OTX2 mRNA single transfections.  More specifically, the results for the single 
mRNA transfections showed approximately 16-32 fold increase for OTX2, and 
approximately a 4 fold increase BLIMP and OC1 (figure 6A). Similar to 
CHERRY transfections, single transfections (BLIMP, OC1 or OTX2 alone) 
decreased overtime until no expression was observed 14-days post transfection 
(data not shown). Interestingly, OC1 and OTX2 mRNA transfected cells showed 
an overexpression in BLIMP, while BLIMP transfected cells exhibited an 
27 
 
increased expression of OTX2 (6A). Taken together this data suggest that these 
three early retinal development genes may work together in the same pathway, 
either upstream or downstream from one another.  
 To further analyze whether these three early genes work together, we 
performed additional transfection of these genes in combinations or two or three. 
OC1 and OTX2 mRNAs were transfected together using the established protocol. 
This double transfection resulted in a four to five fold increase in OC1 and OTX2 
expressions and a one fold increase in BLIMP expression. It was interesting to 
note that the double transfection did not drive OC1 or OTX2 expression 
significantly more than the single mRNA transfections; similarly, BLIMP was 
also expressed in the double transfection (OCI and OTX2 together) as it was in 
the single OC1 or OTX2 mRNA transfections.  When all three mRNAs (BLIMP, 
OC1, and OTX2) were transfected, cells showed an equal expression (4-64 fold 
increase) of all three genes (Figure 6C).  Furthermore, transfecting all three 
mRNA consistently resulted in similar expression levels for all three genes, while 
the double transfection often resulted in more varied results (data not shown). 
Therefore, subsequent transfections in this study consisted of all three mRNAs, 
which will be referred to as “BOO,” for BLIMP, ONECUT1 and OTX2 (Figure 
6C). Using this data, we created an H1 cell mRNA transfection protocol which is 
































































(A) Quantitative RT-PCR analysis indicates that mRNA transfected cells overexpressed each 
target gene accordingly compared to the CHERRY transfection control that expressed none of the 
target genes. Quantitative RT-PCR illustrated duplicate transfection overexpressing all genes, 
more so OC1 and OTX2. (B) A schematic a “BOO” mRNA transfection protocol. (C)The triplicate 
transfection, “BOO,” demonstrated a consistent overexpression for all three genes. 
 
“BOO” increased expression of early photoreceptor factors:  
 Once we have established the successful transfection and expression of 
“BOO,” our next step was to determine if the expression of “BOO” could bias 
cone photoreceptor development. To accomplish this, we again transfected H1 
differentiated neural retinal cells at 3 months of age with BLIMP, OC1 and OTX2 
using established protocols. Cells were collected seven days post transfection for 
RNA extraction and subsequently analysis using qRT-PCR.  Gene expression 
analysis of “BOO” transfected cells showed that there was an increase in 
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expression of multiple photoreceptor factors in comparison to non-transfected 
control cells (Figure 7A). These photoreceptor factors included cone-rod 
homeobox (CRX), neuronal differentiation factor (ND1), and recoverin (REC). 
Moreover, the expression of specific cone photoreceptor factors thyroid hormone 
receptor beta (TRB2) and Retinoid X Receptor, Gamma (RXRG) were also 
upregulated (Figure 7A).  
 While qRT-PCR confirmed that the “BOO” triplicate transfected cells were 
expressing photoreceptor factors at the mRNA level, immunohistochemistry was 
carried out to assess expression level at the protein level for each of the 
corresponding genes. One week after transfection, higher levels of otx2 and 
recoverin proteins, both photoreceptor markers, were seen in “BOO” transfected 
cells when compared to non-transfection control cells. More importantly, RXRG 
protein, an indicator of cone photoreceptor expression, was also noticed (Figure 
7B). This translation further demonstrated that expression of “BOO” not only 
influenced mRNA expression levels of cone photoreceptor associated genes, but 
also resulted in a corresponding expression at the protein level. Furthermore, these 
results confirmed that “BOO” mRNA expression could be sustained over a period 
of about a week. This data suggested that one week of “BOO” overexpression 
may play an important role in cone photoreceptor development in H1 





















































(A) “BOO” transfected cells demonstrated an increase in photoreceptor factors after 7 days. 
“BOO” demonstrated an increase in photoreceptor factors, specifically for cone markers. (B) 
Protein expression level increased for OTX2 and recoverin photoreceptor factors via “BOO” 
transfected cells 7 days post transfection.  
 
“BOO” transfected cells were able to integrate into a mouse host retina: 
 Previous results demonstrated that transient mRNA transfection could 
influence both gene and corresponding protein levels for about a period of one 
week post transfection in H1 differentiated neural retinal stem cells (Figure 7). 
Since the qRT-PCR data consistently validating “BOO” as the preferred 
33 
 
combination of mRNAs used for transfection, further analysis was done by 
injecting these “BOO”-transfected H1 cells into an immunodeficient IL2Rγnull 
mouse cell line. Following the established transfection protocol, H1 differentiated 
neural retinal stem cells were grown to 3 months, infected with a viral GFP. The 
GFP infection would later help track the “BOO”-transfected cells for analysis. 
The GFP+ cells were transfected with “BOO” mRNA combination, and 3 days 
post transfection cells extracted for further animal studies. 
 Following extraction, the cells were injected into the sub-retinal space of the 
host mouse retina by Dr. Jie Zhu (Buck Institute for Research of Aging, Novato, 
CA). One month after injection, mice retinas were collected and GFP fluorescence 
was analyzed for retinal neural cell integration and localization. “BOO” 
transfected (GFP+) cells showed a good survival rate and were seen integrating 
from the sub retinal space into the outer nuclear layer (ONL) of the retina, an area 
otherwise known as the photoreceptor layer (Figure 8A and B). Some of the 
“BOO” transfected (GFP+) cell extensions were also seen integrated into the inner 
nuclear layer (INL). Photoreceptor extensions that leave the INL usually 
communicate directly or indirectly with other retinal neural cells, such as 
amacrine cells, when visual response occurs (4). Collectively, these results 
indicate that 3 month old neural retinal cells transfected with “BOO” increase 
photoreceptor markers, can survive host injections, and can localize in the 











































(A) “BOO” transfected cells (GFP+) were seen surviving in the host retina one month following 






 AMD is a retinal degenerative disease that causes an irreversible loss of 
cone photoreceptor cells. The mammalian retina does not have any cone cell 
regenerative properties on its own; therefore, transplantation of these 
photoreceptor cells for visual restoration is imperative. Stem cells have been used 
for various types of research and treatment, including retinal cell replacement 
therapy for AMD (23). Also, eye field studies have specifically recognized hES 
and iPS cells to have advanced research applications in terms of disease models 
and possible treatments for retinal degenerative diseases (24). However, there is 
minimal success reported for biasing cone photoreceptor fate during 
differentiation from hES or iPS cells.  
 The results above demonstrated that overexpression of three early 
photoreceptor genes could potentially bias cone photoreceptor fate in vitro using 
hES (figure 7). H1 cell line was differentiated into neural retinal stem cells and 
expanded over a period of three months (figure 3). This specific time point was 
used because of its relevance to a natural peak in cone photoreceptor development 
in humans (25) and was further analyzed through qRT-PCR (figure 3). Compared 
to the undifferentiated stem cells, the differentiated hES and iPS cell lines 
demonstrated an upregulation in eye field transcription factors and early retinal 
cell markers such as  crx, a photoreceptor maker, and rxrg, a cone cell marker 
(figure 3F). This large fold change suggested that the cultured cells were at the 
appropriate early stage in development to bias only cone photoreceptor fate.  
 First, hES cells proved to be effective and efficient for using this mRNAs 
transfection protocol (Figure 5). DNA transfection has been used countless times 
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in past cell research; therefore, defining mRNA as an adequate transfection 
method here was important for future research. Furthermore, using this method in 
hES and iPS cells, especially from patients with retinal degenerative diseases, is 
valuable for future therapeutic approaches. Having a more personalized approach 
to medicine is the present focus for most treatments.   
 These studies unveiled consistently high mRNA expression levels for 
several genes of interest days after transfection. Three genes, BLIMP, ONECUT1 
and OTX2, were overexpressed through mRNA transfection to bias cone 
photoreceptor cell fate (figure 6). Analysis via qRT-PCR showed at least a five 
fold increase for each single transfection of BLIMP, ONECUT1 or OTX2 
mRNAs even after 7 days post transfection.  
 Second, a constant 3 fold change for BLIMP, ONECUT1 and OTX2 mRNA 
was seen expressed when all three mRNAs were transfected together, otherwise 
known as “BOO.” With this constant fold change, it was easy to see the stability 
of these mRNAs. Although fold increases were higher in single transfections, all 
three mRNAs demonstrated a link between each other in terms that each gene 
seemed to drive one another (figure 6A) and “BOO” transfections had higher 
levels of expression in several photoreceptor genes when compared to a single 
transfection or a different combination transfection (figure 6B).   
 Specifically, the photoreceptor gene CRX always had at least a 300-400 fold 
increase with “BOO” transfection compared to non-transfected cells. This 
increase in expression for this particular gene could potentially mean that 
transfected cells were biasing neural retinal differentiation into photoreceptor cell 
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fate. Alongside CRX, specific cone photoreceptor factors such as RXRG and TRB2 
were upregulated when cells were transfected with “BOO,” and this could further 
explain the bias of cell fate towards cone photoreceptors. To further support this 
conclusion, immunohistochemistry and in vivo analysis were done. 
Immunohistochemistry demonstrated that these transfected cells stained for 
photoreceptors factors such as OTX2 and recoverin (figure 7B). In vivo analysis 
showed transfected cells predominantly residing in the outer nuclear layer (OPL), 
also known as the photoreceptor layer (figure 8B). 
 Many early onset retinal neural genes such as CRX, neurod1, recoverin, 
RXRG and trb2 demonstrated regulation by a specific over expression of transient 
mRNAs. While all transient mRNAs expressed the above early genes of interest, 
the “BOO” transfection seemed to have more of an impact in regulation even after 
7 days post transfection, leading us to believe that the combination may play a 
more important role in cone development. On the other hand, “BOO” post 
transfections that lasted longer than 7 days post transfection showed a decrease in 
mRNA and protein levels for the three genes (BLIMP, ONECUT1 and OTX2); 
therefore, there was no significant changes in photoreceptor marker expression 
(data not shown). This result could be due to mRNA degradation over a long 
period of time, in which a second round of transfection could be a possible 
solution. On the other hand, in vivo data demonstrates the cells surviving for at 
least one month after injection. This is promising data in which cell death is not 
the cause of mRNA degradation. Further data analysis needs to be done in order to 
see how to bypass mRNA levels lowering after 7 days post transfection. 
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 This study explains one way to bias cone photoreceptor cell fate through a 
stabilized mRNA transfection method. This protocol is important because it could 
potentially be applied to other fields of research or different cell lines/tissues. 
Moreover, future research and treatment is geared towards more personalized 
therapeutics. Experiments that entail hES and iPS cells have grown popular for 
such studies. Lastly, using RNA treatments which will not harm the genome and 
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